• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Pulmonary Alveolar Proteinosis

Pulmonary Alveolar Proteinosis - 18 Studies Found

Completed : Inhalation of Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Autoimmune Pulmonary Alveolar Proteinosis (PAP)
: Autoimmune Pulmonary Alveolar Proteinosis
: 2014-09-14
: Drug: GM-CSF Other Name: HUABEI JIMUXIN
Not yet recruiting : Evaluation of a Single Dose of Inhaled Sargramostim in Patients With Autoimmune Pulmonary Alveolar Proteinosis
: Autoimmune Pulmonary Alveolar Proteinosis
: 2016-11-28
: Drug: Sargramostim Other Names:
  • Leukine
  • recombinant human GM-C

Completed : Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
: Autoimmune Pulmonary Alveolar Proteinosis
: 2016-02-28
:
  • Drug: molgramostim molgramosti

Completed : Whole Lung Lavage (WLL)/Inhaled Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis (PAP)
: Pulmonary Alveolar Proteinosis
: 2009-05-11
:
  • Drug: GM-CSF [Leukine (Sargramostim)]

Completed : A National Registry For Pulmonary Alveolar Proteinosis
: Pulmonary Alveolar Proteinosis
: 2015-05-28
Completed : Multicenter International Cross-Sectional Evaluation of Pulmonary Alveolar Proteinosis Trial
: Pulmonary Alveolar Proteinosis
: 2016-11-28
: Other: Retrospective Chart Review No intervention.
Completed : Inhaled Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in Hereditary Pulmonary Alveolar Proteinosis (PAP)
: Hereditary Pulmonary Alveolar Proteinosis
: 2011-12-12
: Drug: Leukine Participants will receive inhaled rhGM-CSF (Sargramostim, Leukine) at the dose of 250 mcg
Terminated : GM-CSF in Patients With Pulmonary Alveolar Proteinosis
: Pulmonary Alveolar Proteinosis
: 2002-01-30
: Drug: GM-CSF (granulocyte-macrophage colony-stimulating factor, sargramostim)
Active, not recruiting : Pulmonary Alveolar Proteinosis GM-CSF Inhalation Efficacy Trial in Japan
: Pulmonary Alveolar Proteinosis, Autoimmune
: 2016-07-13
:
  • Drug: Sargramostim
  • Drug: Placebo

Completed : Prospective Trial of Rituximab for Primary Pulmonary Alveolar Proteinosis
:
  • Pulmonary Alveolar Proteinosis
  • Primary Disease

: 2007-10-31
: Drug: rituximab IV, 1000 mg, two weeks, 2 times Othe
Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.